Bear Stearns reiterates Amgen at peer perform

Amgen, Inc. was reiterated by Bear Stearns analyst Mark Schoenebaum at peer perform after the company reported second-quarter financial results, raising its 2006 earnings-per-share guidance to $3.75 to $3.85 from $3.60 to $3.70. The analyst believes a decision in the CERA case will come shortly and that things appear favorable for Amgen. Shares of the Thousand Oaks, Calif.-based biotechnology company were up $2.23, or 3.49%, at $66.15 on volume of 21,139,527 shares versus the three-month running average of 8,641,800 shares. (Nasdaq: AMGN)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.